Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data

PLoS One. 2013 May 9;8(5):e62650. doi: 10.1371/journal.pone.0062650. Print 2013.

Abstract

Objective: Predicting the risk of future events is an essential part of health economic simulation models. In pursuit of this goal, the current study aims to predict the risk of developing first and second acute myocardial infarction, heart failure, non-acute ischaemic heart disease, and stroke after diagnosis in patients with type 2 diabetes, using data from the Swedish National Diabetes Register.

Material and methods: Register data on 29,034 patients with type 2 diabetes were analysed over five years of follow up (baseline 2003). To develop and validate the risk equations, the sample was randomly divided into training (75%) and test (25%) subsamples. The Weibull proportional hazard model was used to estimate the coefficients of the risk equations, and these were validated in both the training and the test samples.

Results: In total, 4,547 first and 2,418 second events were observed during the five years of follow up. Experiencing a first event substantially elevated the risk of subsequent events. There were heterogeneities in the effects of covariates within as well as between events; for example, while for females the hazard ratio of having a first acute myocardial infarction was 0.79 (0.70-0.90), the hazard ratio of a second was 1.21 (0.98-1.48). The hazards of second events decreased as the time since first events elapsed. The equations showed adequate calibration and discrimination (C statistics range: 0.70-0.84 in test samples).

Conclusion: The accuracy of health economic simulation models of type 2 diabetes can be improved by ensuring that they account for the heterogeneous effects of covariates on the risk of first and second cardiovascular events. Thus it is important to extend such models by including risk equations for second cardiovascular events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cardiovascular Diseases / economics*
  • Cardiovascular Diseases / etiology
  • Computer Simulation
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / economics*
  • Female
  • Follow-Up Studies
  • Heart Failure / economics
  • Heart Failure / etiology
  • Humans
  • Male
  • Middle Aged
  • Models, Economic*
  • Myocardial Infarction / economics
  • Myocardial Infarction / etiology
  • Myocardial Ischemia / economics
  • Myocardial Ischemia / etiology
  • Proportional Hazards Models
  • Registries / statistics & numerical data
  • Risk Assessment / methods
  • Risk Assessment / statistics & numerical data*
  • Risk Factors
  • Stroke / economics
  • Stroke / etiology
  • Sweden

Grants and funding

A.A.K. received funds from the Health Ministry of Iran to perform this research as a part of his PhD thesis. An unrestricted educational grant from Novo Nordisk Ltd is gratefully acknowledged. The Health Economics Programme (HEP) at Lund University receives core funding from FAS (dnr. 2006-1660), a Government Grant for Clinical Research (ALF) and the Skåne Region (Ulf-G. Gerdtham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.